The GvHD Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Is the microbiota biotherapeutic MaaT013 a safe and effective option for steroid-refractory GI GvHD?

During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the GvHD Hub spoke to Florent Malard, Hôpital Saint-Antoine, Paris, FR. We asked, Is the microbiota biotherapeutic MaaT013 a safe and effective option for steroid-refractory gastrointestinal GvHD?

In this video, Malard reports the promising results from the first 29 patients in France treated with MaaT013 as part of a compassionate use program. MaaT013 represents a promising treatment option for heavily pretreated patients with acute gastrointestinal GvHD.

Share: